CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 82 filers reported holding CYTOSORBENTS CORP in Q3 2018. The put-call ratio across all filers is 0.75 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $94,760 | +20.5% | 11,670 | +28.8% | 0.00% | 0.0% |
| Q1 2021 | $78,658 | -5.9% | 9,062 | -13.6% | 0.00% | 0.0% |
| Q4 2020 | $83,565 | -0.1% | 10,485 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $83,618 | -19.4% | 10,485 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $103,802 | +85.3% | 10,485 | +23.7% | 0.00% | +100.0% |
| Q2 2019 | $56,033 | -12.7% | 8,477 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $64,171 | -23.9% | 8,477 | -18.8% | 0.00% | -50.0% |
| Q4 2018 | $84,371 | -37.4% | 10,442 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $134,702 | -99.9% | 10,442 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $119,039,000 | – | 10,442 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Skylands Capital, LLC | 815,869 | $3,141,000 | 0.46% |
| Sargent Investment Group, LLC | 499,010 | $1,921,000 | 0.36% |
| Anson Funds Management LP | 74,440 | $287,000 | 0.33% |
| One68 Global Capital, LLC | 39,241 | $151,000 | 0.33% |
| Granahan Investment Management | 678,618 | $2,613,000 | 0.12% |
| Winning Points Advisors, LLC | 30,000 | $115,000 | 0.07% |
| Avenir Corp | 150,600 | $580,000 | 0.06% |
| HighMark Wealth Management LLC | 10,000 | $38,000 | 0.04% |
| Wealthcare Advisory Partners LLC | 62,279 | $240,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 64,970 | $250,000 | 0.03% |